Home/Kala Pharmaceuticals/Andrew R. Gow, Ph.D.
AR

Andrew R. Gow, Ph.D.

Chief Scientific Officer

Kala Pharmaceuticals

Kala Pharmaceuticals Pipeline

DrugIndicationPhase
KPI-012Persistent Corneal Epithelial Defects (PCED)Phase 2b